UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (18), p.9134-9142

2006

Volltextzugriff (PDF)

Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA

Molecular cancer therapeutics, 2009-10, Vol.8 (10), p.2780-2790

2009

Volltextzugriff (PDF)

Actinic keratosis modelling in mice: A translational study

PloS one, 2017-06, Vol.12 (6), p.e0179991-e0179991

2017

Volltextzugriff (PDF)

Synthesis and biological evaluation of (-)-6-O-desmethylcryptopleurine and analogs

Bioorganic & medicinal chemistry letters, 2015-01, Vol.25 (2), p.184-187

2015

Volltextzugriff (PDF)

An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II

PloS one, 2011-08, Vol.6 (8), p.e23597

2011

Volltextzugriff (PDF)

Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor

Molecular cancer therapeutics, 2005-04, Vol.4 (4), p.641-649

2005

Volltextzugriff (PDF)

CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans

Journal of dermatological science, 2013-02, Vol.69 (2), p.105-113

2013

Volltextzugriff (PDF)

Optical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal antibody

PloS one, 2012-01, Vol.7 (1), p.e30690

2012

Volltextzugriff (PDF)

Pursaethosides A-E, triterpene saponins from Entada pursaetha

Journal of natural products (Washington, D.C.), 2005-08, Vol.68 (8), p.1185-1190

2005

Volltextzugriff (PDF)

Marked Antitumor Activity of a New Potent Acronycine Derivative in Orthotopic Models of Human Solid Tumors

Clinical cancer research, 2001-08, Vol.7 (8), p.2573-2580

2001

Volltextzugriff (PDF)

Histology and Sensitivity to Anticancer Drugs of Two Human Non-Small Cell Lung Carcinomas Implanted in the Pleural Cavity of Nude Mice

Clinical cancer research, 2000-01, Vol.6 (1), p.297-304

2000

Volltextzugriff (PDF)

Synthesis and Cytotoxic and Antitumor Activity of Esters in the 1,2-Dihydroxy-1,2-dihydroacronycine Series

Journal of medicinal chemistry, 1996-11, Vol.39 (24), p.4762-4766

1996

Volltextzugriff (PDF)

Synthesis of N, N′-disubstituted 3-aminobenzo[ c] and [ d]azepin-2-ones as potent and specific farnesyl transferase inhibitors

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (3), p.767-771

2004

Volltextzugriff (PDF)

The DNA-Binding Polyamine Moiety in the Vectorized DNA Topoisomerase II Inhibitor F14512 Alters Reparability of the Consequent Enzyme-Linked DNA Double-Strand Breaks

Molecular cancer therapeutics, 2017-10, Vol.16 (10), p.2166-2177

2017

Volltextzugriff (PDF)

Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma

Clinical cancer research, 2015-12, Vol.21 (23), p.5314-5323

2015

Volltextzugriff (PDF)

Acronycine derivatives as promising antitumor agents

Anti-cancer drugs, 2002-06, Vol.13 (5), p.445-449

2002

Volltextzugriff (PDF)

Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer

Investigational new drugs, 2019-08, Vol.37 (4), p.693-701

2019

Volltextzugriff (PDF)

The nonlysosomal β‐glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells

The FASEB journal, 2013-02, Vol.27 (2), p.489-498

2013

Volltextzugriff (PDF)

Synthesis and activities towards resistant cancer cells of sulfone and sulfoxide griseofulvin derivatives

Bioorganic & medicinal chemistry letters, 2015-05, Vol.25 (10), p.2078-2081

2015

Volltextzugriff (PDF)

Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II

Biochemical pharmacology, 2011-12, Vol.82 (12), p.1843-1852

2011

Volltextzugriff (PDF)

F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer

Cancer letters, 2016-01, Vol.370 (1), p.10-18

2016

Volltextzugriff (PDF)

Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system

Investigational new drugs, 2011-02, Vol.29 (1), p.9-21

2011

Volltextzugriff (PDF)

F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (23), p.9845-9853

2008

Volltextzugriff (PDF)

Abstract 2428: Translational study of F14512, a novel vectorised epipodophyllotoxin, which demonstrates a marked activity on ovarian cancer models from patients

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2428-2428

2015

Volltextzugriff (PDF)

Discovery bioanalysis and in vivo pharmacology as an integrated process: a case study in oncology drug discovery

Bioanalysis, 2016-07, Vol.8 (14), p.1481-1498

2016

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(67)
Humans
(53)
Animals
(40)
Life Sciences
(36)
Mice
(33)
Female
(28)
Pharmacology & Pharmacy
(27)
Biological And Medical Sciences
(22)
Antineoplastic Agents - Pharmacology
(20)
Medical Sciences
(20)
Physical Sciences
(20)
Cell Line, Tumor
(18)
Pharmacology. Drug Treatments
(18)
Oncology
(17)
Antineoplastic Agents
(16)
Chemistry, Medicinal
(16)
Chemistry
(15)
Male
(15)
Medicine
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties

Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA

Actinic keratosis modelling in mice: A translational study

Synthesis and biological evaluation of (-)-6-O-desmethylcryptopleurine and analogs

An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II

Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor

CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans

Optical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal antibody

Pursaethosides A-E, triterpene saponins from Entada pursaetha

Marked Antitumor Activity of a New Potent Acronycine Derivative in Orthotopic Models of Human Solid Tumors

Histology and Sensitivity to Anticancer Drugs of Two Human Non-Small Cell Lung Carcinomas Implanted in the Pleural Cavity of Nude Mice

Synthesis and Cytotoxic and Antitumor Activity of Esters in the 1,2-Dihydroxy-1,2-dihydroacronycine Series

Synthesis of N, N′-disubstituted 3-aminobenzo[ c] and [ d]azepin-2-ones as potent and specific farnesyl transferase inhibitors

The DNA-Binding Polyamine Moiety in the Vectorized DNA Topoisomerase II Inhibitor F14512 Alters Reparability of the Consequent Enzyme-Linked DNA Double-Strand Breaks

Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma

Acronycine derivatives as promising antitumor agents

Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer

The nonlysosomal β‐glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells

Synthesis and activities towards resistant cancer cells of sulfone and sulfoxide griseofulvin derivatives

Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II

F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer

Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system

F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system

Abstract 2428: Translational study of F14512, a novel vectorised epipodophyllotoxin, which demonstrates a marked activity on ovarian cancer models from patients

Discovery bioanalysis and in vivo pharmacology as an integrated process: a case study in oncology drug discovery

Suchergebnisse filtern